SCHEMBL8176752

SCHEMBL8176752

CC(C)CCc1[c]ccc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ESR1 P03372 2/20 0.36
RORC P51449 1/20 0.34
CYP2A6 P11509 2/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DHODH Q02127 1/20 0.33
KCNJ11 Q14654 1/20 0.32
ELANE P08246 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
HPRT1 P00492 1/20 0.31
HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629871 0.84 ELANE (0.35) ALDH1A1TDP1KMT2AKDM4ELMNA
SCHEMBL808527 0.81 ALDH1A1 (0.40) ALDH1A1TDP1KDM4EGAACYP2A6
SCHEMBL2252836 0.79 GAA (0.39) ALDH1A1TDP1KMT2AKDM4ELMNA
SCHEMBL5024317 0.78 GRIN2D (0.34) ESR1
SCHEMBL4629536 0.77 KCNH2 (0.42) ALDH1A1TDP1KMT2AKDM4ELMNA
SCHEMBL2497729 0.77 MAPT (0.34) ALDH1A1TDP1KDM4EMAPTCYP2A6
SCHEMBL455640 0.77 CYP2A6 (0.39) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL10760575 0.76 KCNH2 (0.44) ALDH1A1TDP1KMT2AKDM4ELMNA
SCHEMBL5750528 0.76 KCNH2 (0.44) ALDH1A1TDP1KMT2AKDM4ELMNA
SCHEMBL292073 0.76 KCNH2 (0.44) ALDH1A1TDP1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147117-A ADMINISTERING TO AIDS PATIENTS TO TREAT HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS (HIV) G. D. SEARLE & CO. (US) 2000-11-14 US disclosed
US-6143747-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 2000-11-07 US disclosed
US-6060476-A α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G. D. SEARLE & CO. (US) 2000-05-09 US disclosed
US-6046190-A FOR INHIBITING RETROVIRAL PROTEASES SUCH AS HUMAN IMMUNODEFICIENCY VIRUS G.D. SEARLE & CO. (US) 2000-04-04 US disclosed
US-5965588-A COMPOUNDS PARTICULARLY USEFUL AS INHIBITORS OF HIV PROTEASE G.D. SEARLE & CO. (US) 1999-10-12 US disclosed
US-5843946-A α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1998-12-01 US disclosed
US-5760064-A RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE (US) 1998-06-02 US disclosed
US-5744481-A β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1998-04-28 US disclosed
US-5639769-A ADMINISTERING ANTIVIRAL AGENT G.D. SEARLE AND CO. (US) 1997-06-17 US disclosed
US-5521219-A TREATMENT OF AIDS G. D. SEARLE & CO. (US) 1996-05-28 US disclosed
US-5510388-A TREATING HTLV, AIDS G. D. SEARLE & CO. (US) 1996-04-23 US disclosed